Healthcare >> CEO Interviews >> November 1, 2002

Lawrence Bloch – Applied Molecular Evolution Inc (amev)

DR. LAWRENCE E. BLOCH has been Chief Financial Officer of Applied Molecular Evolution, Inc., since March 2000 and Secretary since April 2000. From 1999 to 2002 he was Vice President of Business Development. From 1998 to 1999, he served as a consultant to several private biotechnology companies, including Applied Molecular Evolution and U.S. Genomics, Inc. In 1995, Dr. Bloch co-founded CareCom, Inc., a developer of patient-oriented bioinformatics applications, and served as its President from 1995 to 1999. Dr. Bloch received a JD from Harvard Law School, an MD from Harvard Medical School and an MBA from Harvard Business School. Dr. Bloch is also a member of the Board of Directors of AME's subsidiary, Novasite Pharmaceuticals, Inc. Profile
TWST: Could we start out with an update on Applied Molecular

Evolution? What has gone on over the past couple of quarters that

investors should focus on?

Dr. Bloch: Since December 2001 we've